Spinal Matrix Metalloproteinase-9 Contributes to Physical Dependence on Morphine in Mice

Abstract

Preventing and reversing opioid dependence continues to be a clinical challenge and underlying mechanisms of opioid actions remain elusive. We report that matrix metalloproteinase-9 (MMP-9) in the spinal cord contributes to development of physical dependence on morphine. Chronic morphine exposure and naloxone-precipitated withdrawal increase activity of spinal MMP-9. Spinal inhibition or targeted mutation of MMP-9 suppresses behavioral signs of morphine withdrawal and the associated neurochemical alterations. The increased MMP-9 activity is mainly distributed in the superficial dorsal horn and colocalized primarily with neurons and small numbers of astrocytes and microglia. Morphine exposure and withdrawal increase phosphorylation of NR1 and NR2B receptors, ERK1/2, calmodulin-dependent kinase II, and cAMP response element binding proteins; and such phosphorylation is suppressed by either spinal inhibition or targeted mutation of MMP-9. Further, spinal administration of exogenous MMP-9 induces morphine withdrawal-like behavioral signs and mechanical allodynia, activates NR1 and NR2 receptors, and downregulates integrin-␤1, while a function-neutralizing antibody against integrin-␤1 suppresses MMP-9-induced phosphorylation of NR1 and NR2B. Morphine withdrawal-induced MMP-9 activity is also reduced by an nNOS inhibitor. Thus, we hypothesize that spinalMMP-9maycontributetothedevelopmentofmorphinedependenceprimarilythroughneuronalactivationandinteractionwithNR1and NR2B receptors via integrin-␤1 and NO pathways. The other gelatinase, MMP-2, is not involved in morphine dependence. Inhibiting spinal MMP-9 or MMP-2 reduces chronic and/or acute morphine tolerance. This study suggests a novel therapeutic approach for preventing, minimizing, or reversing opioid dependence and tolerance.

WNT signaling underlies the pathogenesis of neuropathic pain in rodents

“…The average green fluorescence intensity of each pixel was normalized to the background intensity in the same image. These protocols were similar to those described previously (22,54). The same methods were used to obtain quantitative measurements of FZ1, FZ8, and β-catenin immunofluorescence in DRG.…”

Blocking EphB1 Receptor Forward Signaling in Spinal Cord Relieves Bone Cancer Pain and Rescues Analgesic Effect of Morphine Treatment in Rodents

“…Protocols were similar to those described previously (14,21). EphB1 and ephrinB2 were immunoprecipitated from 2 mg total protein/mL tissue lysate by using an anti-EphB1 antibody [2 mg; Santa Cruz Technology (SCT)] complex with protine Gagarose (Invitrogen) and wheat germ agglutinin linked to agarose (Sigma), respectively.…”

“…Morphologic details were examined with a confocal microscope (Leica TCS SP2, Germany). The protocols were similar to those described previously (14,21).…”

Secreted tissue inhibitor of matrix metalloproteinase restricts trans-synaptic signaling to coordinate synaptogenesis

“…Whenever Mmp regulation is disrupted, developmental abnormalities and disease often result (Huntley, 2012;Malemud, 2006). Improper Mmp expression and activity is implicated in a range of neurological disorders, including schizophrenia (Lepeta and Kaczmarek, 2015), addiction (Liu et al, 2010), epilepsy (Pollock et al, 2014) and autism spectrum disorder (ASD) (Abdallah and Michel, 2013). As the most common heritable ASD and intellectual disability, Fragile X syndrome (FXS) underscores the importance of preserving Mmp balance to control proper synaptic structure and function (Reinhard et al, 2015;Siller and Broadie, 2011).…”